Startseite>>Lipids>> Endocannabinoid/Endocannabinoid-like>>N-Cyclohexanecarbonyltetradecylamine

N-Cyclohexanecarbonyltetradecylamine

Katalog-Nr.GC44340

Numerous analogs of fatty acyl ethanolamides potentiate the intrinsic biological activity of endocannabinoids.

Products are for research use only. Not for human use. We do not sell to patients.

N-Cyclohexanecarbonyltetradecylamine Chemische Struktur

Cas No.: 1215071-05-8

Größe Preis Lagerbestand Menge
5mg
46,00 $
Auf Lager
10mg
88,00 $
Auf Lager
50mg
371,00 $
Auf Lager
100mg
648,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Numerous analogs of fatty acyl ethanolamides potentiate the intrinsic biological activity of endocannabinoids. This potentiation is ascribed either to inhibition of AEA reuptake into neurons, or inhibition of fatty acid amide hydrolase (FAAH) within the neurons. However, Ueda, et al. has recently cloned another amidase, the acidic PEAase that promotes the hydrolysis of palmitoylethanolamide. N-Cyclohexanecarbonyltetradecylamine is an analog of N-cyclohexanecarbonyl-pentadecylamine, a selective inhibitor of acidic PEAase with an IC50 value of 4.5 µM, that contains 1 less carbon in the alkyl chain. The biological activity of N-cyclohexanecarbonyltetradecylamine has not been documented.

Bewertungen

Review for N-Cyclohexanecarbonyltetradecylamine

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-Cyclohexanecarbonyltetradecylamine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.